Study guide
9.4 Vaccination & Travel Health
APC Intern Written Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Pathway to General Registration 1.3 Restricted Open-Book Strategy (AMH & APF) 1.4 Scoring, Results & Appeals
2 Legal Framework: PBS & Medicine Schedules
2.1 PBS, Authority Prescriptions & Special Access Scheme 2.2 Schedules 2 & 3 (Pharmacy & Pharmacist Only Medicines) 2.3 Schedules 4 & 8 (Prescription Only & Controlled Drugs)
3 Legal Framework: Privacy, National Law & Pharmacy Board
3.1 Privacy, Confidentiality & Patient Rights 3.2 Health Practitioner National Law & Registration 3.3 Pharmacy Board Codes, Guidelines & Standards
4 Patient-Centred Medication Management
4.1 Assessing Clinical Situations & Treatment Options 4.2 Patient Factors: Adherence, Efficacy & Safety 4.3 Drug & Dosage-Form Factors 4.4 Culturally Responsive Medication Management
5 Primary Care & Judicious Use of Medicines
5.1 Primary Care & OTC Assessment 5.2 Judicious Use of Antimicrobials & High-Risk Agents 5.3 Non-Pharmacological Options & Evidence-Based OTC Choices
6 Dispensing & Clinical Appropriateness
6.1 Prescription Evaluation 6.2 Clinical Appropriateness Checks 6.3 Labelling, Packaging & Dispensing Standards 6.4 Communicating with Prescribers & Documenting Changes
7 Counselling & Acute Care
7.1 Patient-Centred Counselling 7.2 Confirming Understanding & Lifestyle Counselling 7.3 Acute Illness, Injury & Emergency Response
8 Therapeutics: Cardiovascular & Endocrine
8.1 Hypertension & Heart Failure 8.2 Ischaemic Heart Disease & Anticoagulation 8.3 Diabetes Medicines 8.4 Thyroid & Lipid Disorders
9 Therapeutics: Infection, Respiratory & Gastrointestinal
9.1 Anti-Infectives & Infection Management 9.2 Asthma & COPD 9.3 Gastrointestinal & Hepatic Conditions 9.4 Vaccination & Travel Health
10 Therapeutics: Neurology, Psychiatry & Pain
10.1 Epilepsy & Movement Disorders 10.2 Depression, Anxiety & Psychosis 10.3 Pain Management & Opioids 10.4 Migraine & Common Analgesics
11 Therapeutics: Special Populations & Systems
11.1 Women's Health, Contraception & Pregnancy 11.2 Dermatology, Ophthalmology & ENT 11.3 Renal/Hepatic Impairment & Dose Adjustment
12 Therapeutics: Rheumatology, Haematology, Urology, Oncology & Toxicology
12.1 Rheumatology: Gout, Osteoarthritis & Inflammatory Arthritis 12.2 Haematology: Anaemias & Blood Safety Monitoring 12.3 Urology & Men's Health 12.4 Oncology Support & Oral Anticancer Medicines 12.5 Toxicology & Poisoning Management
13 Monitoring: Clinical Review
13.1 Clinical Review Process 13.2 Interpreting Laboratory & Clinical Monitoring 13.3 Recommending Treatment Modifications
14 Monitoring: Safety & Adverse Drug Reactions
14.1 Adverse Drug Reactions & Reporting 14.2 Allergies, Sensitivities & Cross-Reactivity 14.3 High-Risk Medicines Monitoring
15 Compounding Medicines
15.1 Determining Required Formulations 15.2 Compounding Standards & Quality 15.3 Patient-Specific Preparations
16 Pharmaceutical Calculations
16.1 Dosage Calculations 16.2 Concentrations, Dilutions & Alligation 16.3 Half-Life & Basic Kinetic Calculations
17 Promote Health & Well-Being
17.1 National & Local Health Priorities 17.2 Screening Programs & Pharmacist Role 17.3 Culturally Responsive Promotion & Self-Sufficiency
9.4 Vaccination & Travel Health
Key Takeaways Explain This Topic AI
Pharmacist vaccination authority in Australia is jurisdiction-specific — know that scope, approved vaccines, age limits, and training requirements vary by state and territory.
Cold chain integrity, informed consent, and anaphylaxis preparedness (including adrenaline) are non-negotiable safety systems for every immunisation encounter.
National Immunisation Program (NIP) schedules provide funded vaccines for key groups; pharmacists support access, catch-up awareness, and accurate record pathways.
Influenza, COVID-19, pneumococcal, and zoster vaccines are high-volume adult counselling opportunities with group-specific recommendations.
Travel health combines destination risk assessment, routine schedule catch-up, selected travel vaccines, and malaria chemoprophylaxis adherence counselling — delivered with respectful communication for vaccine hesitancy.
Last updated: August 2026
9.4 Vaccination & Travel Health
Quick Answer: Pharmacist immunisation is a state/territory-regulated advanced practice: confirm your legal scope, maintain cold chain , obtain informed consent , prepare for anaphylaxis , align with the National Immunisation Program and current ATAGI-aligned guidance, and counsel high-volume vaccines (influenza, COVID-19, pneumococcal, zoster) plus travel risks including malaria prophylaxis adherence. Communicate respectfully with hesitant patients using evidence and autonomy.
Vaccination sits at the intersection of Competency 3.6 (health promotion) and 3.1–3.3 (assessment, implementation, monitoring). The Intern Written Examination tests principles and safety systems more than memorising every brand name.
Pharmacist vaccination role in Australia (jurisdictional principles)
Australia does not have a single identical national pharmacist vaccination law for every antigen and age. Instead:
Each state and territory defines which vaccines pharmacists may administer, under what training/certification, in which settings, and for which age groups
National frameworks and programs (NIP funding, Australian Immunisation Handbook guidance, ATAGI statements) inform what is recommended , while local Drugs and Poisons / pharmacy legislation inform who may administer
Intern pharmacists must know their supervised practice rules — observation, countersigning, and restrictions differ from fully registered pharmacist immunisers
Exam principle: When a scenario asks whether a pharmacist “can vaccinate,” the correct reasoning includes jurisdiction + training + vaccine type + patient age/eligibility , not a blanket yes/no for all of Australia.
Community roles beyond injection:
- Opportunistic recommendation and booking
- Screening for contraindications and precautions
- Cold chain receiving and storage
- Documentation and immunisation register reporting pathways used locally
- Post-vaccination observation and adverse event advice
- Referral when complex medical history exceeds pharmacist protocol
- Cold chain
Vaccines are biological products: potency fails if temperatures breach recommended ranges (commonly +2 °C to +8 °C for many refrigerated vaccines — always follow product and handbook requirements; some have frozen storage or special conditions).
Cold chain essentials:
- Control Why it matters
- Monitored pharmaceutical refrigerator Domestic fridges have unsafe temperature swings
- Continuous temperature logging / twice-daily checks Detect excursions early
- No storage in door shelves / against walls that freeze Hot and cold spots destroy potency
- Validated packaging for transport Outreach and off-site clinics
- Quarantine and report excursions Do not guess “probably fine” after a breach
- Stock rotation (FEFO) Prevent expiry waste and aged stock use
If cold chain fails, isolate stock, document, contact manufacturer/public health advice pathways as required, and do not administer compromised vaccines. Intern scenarios reward quarantine + escalate , not “use it anyway because the patient is waiting.”
Informed consent
Consent must be voluntary, informed, and capacity-based (parent/guardian for children per local rules). Provide in plain language:
- Disease risk being prevented
- Vaccine benefits and common adverse effects (local soreness, low-grade fever, fatigue)
- Rare serious risks (including anaphylaxis)
- Alternatives (including declining)
- Opportunity for questions
Screen before vaccination: allergies to vaccine components (e.g. prior anaphylaxis to a component), acute severe febrile illness (deferral decisions), pregnancy considerations for live vaccines, immunosuppression for live vaccines, and recent other vaccines when spacing rules apply. Document consent and batch details per protocol.
Anaphylaxis preparedness
Every immunisation setting needs:
Immediate access to adrenaline (epinephrine) in correct strengths/devices per protocol
Trained staff who can recognise anaphylaxis (respiratory compromise, hypotension, urticaria/angioedema, collapse)
- Emergency response plan and ability to call ambulance
- Post-vaccination observation period (commonly around 15 minutes; longer if higher risk)
- Incident documentation and adverse event reporting pathways (including TGA/state systems as applicable)
Mild vasovagal syncope is not anaphylaxis — but you must differentiate. Lay the patient flat if faint; for anaphylaxis follow adrenaline-first emergency algorithms. Do not administer vaccines in settings without emergency readiness.
National Immunisation Program (NIP) awareness
The NIP funds scheduled vaccines for eligible groups across the life course (infants, children, adolescents, pregnancy programs, older adults, and risk groups). Exact funded products and ages update — use current NIP schedule and Handbook for detail.
Pharmacist value:
- Identify people overdue for funded vaccines
- Explain eligibility (age, Aboriginal and Torres Strait Islander status, medical risk conditions, pregnancy)
- Support catch-up schedules without unnecessary restarts when valid doses exist
- Direct people to GPs/clinics when the required vaccine is outside pharmacist scope or needs medical assessment
Australian Immunisation Register (AIR) recording supports continuity and school/work evidence where required.
- High-volume adult vaccine concepts
- Influenza
Annual influenza vaccination is recommended for broad groups, with strong emphasis on older adults, pregnant people, young children in schedule groups, Aboriginal and Torres Strait Islander peoples, and those with chronic disease. Counsel: vaccines do not cause influenza disease from inactivated products used in standard programs; protection is partial but reduces severe outcomes; best given before the season peaks but still useful when circulating. Egg allergy pathways have modernised — follow current Handbook (severe anaphylaxis history still needs specialist pathways).
COVID-19
Recommendations evolve with epidemiology and ATAGI updates (primary courses, boosters, risk-group prioritisation, pregnancy guidance). Pharmacists must use current advice rather than outdated 2021 talking points. Counsel expected reactogenicity, rare serious adverse events in context of disease risk, and co-administration rules when allowed.
Pneumococcal
Pneumococcal vaccines protect against invasive disease and pneumonia risk groups (older adults, immunocompromised, chronic disease, some Indigenous populations with specific schedules). Product choice (conjugate vs polysaccharide pathways) and spacing are schedule-specific — verify Handbook rather than improvising brand swaps.
Zoster (shingles)
Recombinant zoster vaccine programs for older adults (and some immunocompromised groups under evolving rules) reduce shingles and post-herpetic neuralgia risk. Counsel two-dose completion when a multi-dose course is indicated, expected local/systemic reactogenicity, and that prior shingles does not always remove benefit of vaccination after recovery (timing per guidance).
- Vaccine area Pharmacist counselling focus
- Influenza Annual timing, risk groups, expectations of benefit
- COVID-19 Current booster eligibility, reactogenicity, evolving guidance
- Pneumococcal Risk-group schedules, product/spacing accuracy
- Zoster Age/risk eligibility, multi-dose completion, reactogenicity
- Travel vaccines and malaria chemoprophylaxis (high-level)
Travel consults start with destination, itinerary, duration, season, activities (rural, medical work), pregnancy, immunosuppression, and routine schedule status . Not every traveller needs every exotic vaccine.
Common travel-related immunisations (examples of categories, not a complete prescription list):
- Hepatitis A , typhoid for many food/water risk itineraries
- Hepatitis B if not immune and risk of blood/sexual exposure
- Rabies pre-exposure for selected high-risk travel
- Japanese encephalitis , yellow fever , meningococcal for specific regions/activities
- Cholera rarely for standard tourists
Yellow fever has international certificate requirements for some borders — timing matters.
Malaria chemoprophylaxis counselling
For malaria-risk regions, prevention is bite avoidance + chemoprophylaxis when indicated + urgent fever assessment after return .
High-level agent classes (selection is medical/itinerary-specific):
Atovaquone–proguanil — daily; start before arrival, continue after leaving risk area per product timing; well tolerated for many short trips; cost considerations
Doxycycline — daily; photosensitivity and oesophagitis counselling; continue after leaving risk area; not for pregnancy/young children when alternatives exist
Mefloquine — weekly regimens in some pathways; neuropsychiatric adverse effect screening and contraindications critical
Adherence counselling is the intervention: missing doses collapses protection. Explain start/stop windows relative to travel dates, take with food if required, and that prophylaxis is not 100% — fever during/after travel is an emergency medical review, mentioning travel history.
Standby emergency treatment concepts exist in specialist advice for selected travellers — not casual OTC improvisation.
Vaccine hesitancy — respectful communication
Hesitancy is common and multi-causal (safety fears, mistrust, access, misinformation, cultural factors). Effective pharmacist communication:
- Listen without ridicule — ask what specifically worries them
- Acknowledge emotions and prior experiences
- Share clear evidence on benefits and known risks in proportion
- Correct specific myths gently with Handbook-aligned facts
- Support autonomy — informed adults can decline; keep the door open
- Avoid coercive shaming that destroys therapeutic relationship
- For parents, focus on protecting the child and community, and offer reliable resources
Motivational interviewing style beats argument. Document discussions and offer follow-up.
Adverse events and reporting
Explain common self-limiting reactions and when to seek care (high fever, extensive swelling, dyspnoea, urticaria, neurological symptoms). Serious events need medical care and formal reporting. Pharmacists contribute to vaccine safety surveillance by reporting suspected adverse events following immunisation.
Exam mindset
Intern Written vaccination items reward jurisdictional humility , cold chain discipline , consent quality , anaphylaxis readiness , NIP eligibility thinking , accurate adult vaccine counselling , travel risk assessment logic , malaria adherence , and respectful hesitancy communication . When schedules change, principles remain: right patient, right vaccine, right storage, right consent, right emergency plan.